{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T17:14:35Z","timestamp":1765041275176},"reference-count":47,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,17]]},"DOI":"10.7759\/cureus.23263","type":"journal-article","created":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T15:19:28Z","timestamp":1647530368000},"source":"Crossref","is-referenced-by-count":3,"title":["Clinical and Epidemiological Characteristics of Stenotrophomonas maltophilia Associated Lower Respiratory Tract Infections in Qatar: A Retrospective Study"],"prefix":"10.7759","author":[{"given":"Arun P","family":"Nair","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sreethish","family":"Sasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muna","family":"Al Maslamani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullatif","family":"Al-khal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kadavil","family":"Chacko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anand","family":"Deshmukh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Abukhattab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-003-3113-6","article-title":"Stenotrophomonas (Xanthomonas) maltophilia as an emerging opportunistic pathogen in association with HIV infection: a 10-year surveillance study","volume":"31","author":"Calza L","year":"2003","unstructured":"Calza L, Manfredi R, Chiodo F. Stenotrophomonas (Xanthomonas) maltophilia as an emerging opportunistic pathogen in association with HIV infection: a 10-year surveillance study. Infection. 2003, 31:155-61. 10.1007\/s15010-003-3113-6","journal-title":"Infection"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.11.1.57","article-title":"Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia","volume":"11","author":"Denton M","year":"1998","unstructured":"Denton M, Kerr KG. Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev. 1998, 11:57-80. 10.1128\/CMR.11.1.57","journal-title":"Clin Microbiol Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.2.413-419.2001","article-title":"Plasmid location and molecular heterogeneity of the L1 and L2 beta-lactamase genes of Stenotrophomonas maltophilia","volume":"45","author":"Avison MB","year":"2001","unstructured":"Avison MB, Higgins CS, von Heldreich CJ, Bennett PM, Walsh TR. Plasmid location and molecular heterogeneity of the L1 and L2 beta-lactamase genes of Stenotrophomonas maltophilia. Antimicrob Agents Chemother. 2001, 45:413-9. 10.1128\/AAC.45.2.413-419.2001","journal-title":"Antimicrob Agents Chemother"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.4.921","article-title":"Overexpression, purification, and characterization of the cloned metallo-beta-lactamase L1 from Stenotrophomonas maltophilia","volume":"42","author":"Crowder MW","year":"1998","unstructured":"Crowder MW, Walsh TR, Banovic L, Pettit M, Spencer J. Overexpression, purification, and characterization of the cloned metallo-beta-lactamase L1 from Stenotrophomonas maltophilia. Antimicrob Agents Chemother. 1998, 42:921-6. 10.1128\/AAC.42.4.921","journal-title":"Antimicrob Agents Chemother"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1086\/514909","article-title":"Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria","volume":"27","author":"Hancock RE","year":"1998","unstructured":"Hancock RE. Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria. Clin Infect Dis. 1998, 27:S93-9. 10.1086\/514909","journal-title":"Clin Infect Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg148","article-title":"Role of the acetyltransferase AAC(6')-Iz modifying enzyme in aminoglycoside resistance in Stenotrophomonas maltophilia","volume":"51","author":"Li XZ","year":"2003","unstructured":"Li XZ, Zhang L, McKay GA, Poole K. Role of the acetyltransferase AAC(6')-Iz modifying enzyme in aminoglycoside resistance in Stenotrophomonas maltophilia. J Antimicrob Chemother. 2003, 51:803-11. 10.1093\/jac\/dkg148","journal-title":"J Antimicrob Chemother"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.10.2317","article-title":"Susceptibilities of 123 strains of Xanthomonas maltophilia to eight beta-lactams (including beta-lactam-beta-lactamase inhibitor combinations) and ciprofloxacin tested by five methods","volume":"38","author":"Pankuch GA","year":"1994","unstructured":"Pankuch GA, Jacobs MR, Rittenhouse SF, Appelbaum PC. Susceptibilities of 123 strains of Xanthomonas maltophilia to eight beta-lactams (including beta-lactam-beta-lactamase inhibitor combinations) and ciprofloxacin tested by five methods. Antimicrob Agents Chemother. 1994, 38:2317-22. 10.1128\/AAC.38.10.2317","journal-title":"Antimicrob Agents Chemother"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-007-0279-3","article-title":"Antimicrobial therapy for Stenotrophomonas maltophilia infections","volume":"26","author":"Nicodemo AC","year":"2007","unstructured":"Nicodemo AC, Paez JI. Antimicrobial therapy for Stenotrophomonas maltophilia infections. Eur J Clin Microbiol Infect Dis. 2007, 26:229-37. 10.1007\/s10096-007-0279-3","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01774-09","article-title":"Antimicrobial susceptibilities of a worldwide collection of Stenotrophomonas maltophilia isolates tested against tigecycline and agents commonly used for S. maltophilia infections","volume":"54","author":"Farrell DJ","year":"2010","unstructured":"Farrell DJ, Sader HS, Jones RN. Antimicrobial susceptibilities of a worldwide collection of Stenotrophomonas maltophilia isolates tested against tigecycline and agents commonly used for S. maltophilia infections. Antimicrob Agents Chemother. 2010, 54:2735-7. 10.1128\/AAC.01774-09","journal-title":"Antimicrob Agents Chemother"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0112208","article-title":"Risk factors and outcomes of Stenotrophomonas maltophilia bacteraemia: a comparison with bacteraemia caused by Pseudomonas aeruginosa and Acinetobacter species","volume":"9","author":"Hotta G","year":"2014","unstructured":"Hotta G, Matsumura Y, Kato K, et al.. Risk factors and outcomes of Stenotrophomonas maltophilia bacteraemia: a comparison with bacteraemia caused by Pseudomonas aeruginosa and Acinetobacter species. PLoS One. 2014, 9:e112208. 10.1371\/journal.pone.0112208","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-011-1459-8","article-title":"Stenotrophomonas maltophilia in the respiratory tract of medical intensive care unit patients","volume":"31","author":"Saugel B","year":"2012","unstructured":"Saugel B, Eschermann K, Hoffmann R, et al.. Stenotrophomonas maltophilia in the respiratory tract of medical intensive care unit patients.  Eur J Clin Microbiol Infect Dis. 2012, 31:1419-28. 10.1007\/s10096-011-1459-8","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.02276","article-title":"Stenotrophomonas maltophilia as an emerging ubiquitous pathogen: looking beyond contemporary antibiotic therapy","volume":"8","author":"Adegoke AA","year":"2017","unstructured":"Adegoke AA, Stenstr\u00f6m TA, Okoh AI. Stenotrophomonas maltophilia as an emerging ubiquitous pathogen: looking beyond contemporary antibiotic therapy. Front Microbiol. 2017, 8:2276. 10.3389\/fmicb.2017.02276","journal-title":"Front Microbiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/2333392819870774","article-title":"Prevalence and antibiotic resistance of Stenotrophomonas maltophilia in respiratory tract samples: a 10-year epidemiological snapshot","volume":"6","author":"Gajd\u00e1cs M","year":"2019","unstructured":"Gajd\u00e1cs M, Urb\u00e1n E. Prevalence and antibiotic resistance of Stenotrophomonas maltophilia in respiratory tract samples: a 10-year epidemiological snapshot. Health Serv Res Manag Epidemiol. 2019, 6:2333392819870774. 10.1177\/2333392819870774","journal-title":"Health Serv Res Manag Epidemiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.157.2.9705064","article-title":"Ventilator-associated pneumonia caused by potentially drug-resistant bacteria","volume":"157","author":"Trouillet JL","year":"1998","unstructured":"Trouillet JL, Chastre J, Vuagnat A, Joly-Guillou ML, Combaux D, Dombret MC, Gibert C. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med. 1998, 157:531-9. 10.1164\/ajrccm.157.2.9705064","journal-title":"Am J Respir Crit Care Med"},{"key":"ref15","unstructured":"Pneumonia (Ventilator-associated [VAP] and non-ventilator-associated Pneumonia [PNEU]) Event . (2022). Accessed. January 31, 2022: http:\/\/www.cdc.gov\/nhsn\/pdfs\/pscmanual\/6pscvapcurrent.pdf."},{"key":"ref16","article-title":"Pneumonia Essentials","author":"Cunha BA","year":"2010","unstructured":"Cunha BA. Pneumonia Essentials. Physicians Press. Cunha BA (ed): Michigan; 2010."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200405-644ST","article-title":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia","volume":"171","year":"2005","unstructured":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005, 171.388-416. 10.1164\/rccm.200405-644ST","journal-title":"Am J Respir Crit Care Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1053\/hl.1999.v28.a96418","article-title":"Stenotrophomonas maltophilia infection and colonization in the intensive care units of two community hospitals: a study of 143 patients","volume":"28","author":"Gopalakrishnan R","year":"1999","unstructured":"Gopalakrishnan R, Hawley HB, Czachor JS, Markert RJ, Bernstein JM. Stenotrophomonas maltophilia infection and colonization in the intensive care units of two community hospitals: a study of 143 patients. Heart Lung. 1999, 28:134-41. 10.1053\/hl.1999.v28.a96418","journal-title":"Heart Lung"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1086\/340707","article-title":"Attributable mortality of Stenotrophomonas maltophilia bacteremia","volume":"34","author":"Senol E","year":"2002","unstructured":"Senol E, DesJardin J, Stark PC, Barefoot L, Snydman DR. Attributable mortality of Stenotrophomonas maltophilia bacteremia. Clin Infect Dis. 2002, 34:1653-6. 10.1086\/340707","journal-title":"Clin Infect Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1080\/23744235.2020.1734653","article-title":"Risk factors for 30-day mortality among patients with Stenotrophomonas maltophilia bacteraemia","volume":"52","author":"Hashimoto T","year":"2020","unstructured":"Hashimoto T, Komiya K, Fujita N, et al.. Risk factors for 30-day mortality among patients with Stenotrophomonas maltophilia bacteraemia. Infect Dis (Lond). 2020, 52:440-2. 10.1080\/23744235.2020.1734653","journal-title":"Infect Dis (Lond)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.05.00096704","article-title":"Significance of positive Stenotrophomonas maltophilia culture in acute respiratory tract infection","volume":"25","author":"Pathmanathan A","year":"2005","unstructured":"Pathmanathan A, Waterer GW. Significance of positive Stenotrophomonas maltophilia culture in acute respiratory tract infection. Eur Respir J. 2005, 25:911-4. 10.1183\/09031936.05.00096704","journal-title":"Eur Respir J"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.36.7.1953-1958.1998","article-title":"Molecular epidemiology of Stenotrophomonas maltophilia isolated from clinical specimens from patients with cystic fibrosis and associated environmental samples","volume":"36","author":"Denton M","year":"1998","unstructured":"Denton M, Todd NJ, Kerr KG, Hawkey PM, Littlewood JM. Molecular epidemiology of Stenotrophomonas maltophilia isolated from clinical specimens from patients with cystic fibrosis and associated environmental samples. J Clin Microbiol. 1998, 36:1953-8. 10.1128\/JCM.36.7.1953-1958.1998","journal-title":"J Clin Microbiol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1086\/317473","article-title":"Nonrespiratory Stenotrophomonas maltophilia infection at a children's hospital","volume":"31","author":"Sattler CA","year":"2000","unstructured":"Sattler CA, Mason EO Jr, Kaplan SL. Nonrespiratory Stenotrophomonas maltophilia infection at a children's hospital. Clin Infect Dis. 2000, 31:1321-30. 10.1086\/317473","journal-title":"Clin Infect Dis"},{"key":"ref24","doi-asserted-by":"crossref","DOI":"10.2307\/30145475","article-title":"Nosocomial infection caused by Xanthomonas maltophilia: a case-control study of predisposing factors","volume":"11","author":"Elting LS","year":"1990","unstructured":"Elting LS, Khardori N, Bodey GP, Fainstein V. Nosocomial infection caused by Xanthomonas maltophilia: a case-control study of predisposing factors. Infect Control Hosp Epidemiol. 1990, 11:134-138.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-008-0518-2","article-title":"Factors associated with mortality in patients with bloodstream infection and pneumonia due to Stenotrophomonas maltophilia","volume":"27","author":"Paez JI","year":"2008","unstructured":"Paez JI, Tengan FM, Barone AA, Levin AS, Costa SF. Factors associated with mortality in patients with bloodstream infection and pneumonia due to Stenotrophomonas maltophilia. Eur J Clin Microbiol Infect Dis. 2008, 27:901-6. 10.1007\/s10096-008-0518-2","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref26","article-title":"Independent predictors for mortality in patients with positive Stenotrophomonas maltophilia cultures","volume":"37","author":"Kwa AL","year":"2008","unstructured":"Kwa AL, Low JG, Lim TP, Leow PC, Kurup A, Tam VH. Independent predictors for mortality in patients with positive Stenotrophomonas maltophilia cultures. Ann Acad Med Singap. 2008, 37:826-830.","journal-title":"Ann Acad Med Singap"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3201\/eid0809.010535","article-title":"Characterization of flagella produced by clinical strains of Stenotrophomonas maltophilia","volume":"8","author":"de Oliveira-Garcia D","year":"2002","unstructured":"de Oliveira-Garcia D, Dall'Agnol M, Rosales M, Azzuz AC, Martinez MB, Gir\u00f3n JA. Characterization of flagella produced by clinical strains of Stenotrophomonas maltophilia. Emerg Infect Dis. 2002, 8:918-23. 10.3201\/eid0809.010535","journal-title":"Emerg Infect Dis"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00051-05","article-title":"Ventilator-associated pneumonia: diagnosis, treatment, and prevention","volume":"19","author":"Koenig SM","year":"2006","unstructured":"Koenig SM, Truwit JD. Ventilator-associated pneumonia: diagnosis, treatment, and prevention. Clin Microbiol Rev. 2006, 19:637-657. 10.1128\/CMR.00051-05","journal-title":"Clin Microbiol Rev"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.87","article-title":"Stenotrophomonas maltophilia infection in hematopoietic SCT recipients: high mortality due to pulmonary hemorrhage","volume":"48","author":"Tada K","year":"2013","unstructured":"Tada K, Kurosawa S, Hiramoto N, et al.. Stenotrophomonas maltophilia infection in hematopoietic SCT recipients: high mortality due to pulmonary hemorrhage. Bone Marrow Transplant. 2013, 48:74-9. 10.1038\/bmt.2012.87","journal-title":"Bone Marrow Transplant"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3062.2011.00710.x","article-title":"Rapidly progressive fatal hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in hematologic malignancy","volume":"14","author":"Araoka H","year":"2012","unstructured":"Araoka H, Fujii T, Izutsu K, et al.. Rapidly progressive fatal hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in hematologic malignancy. Transpl Infect Dis. 2012, 14:355-63. 10.1111\/j.1399-3062.2011.00710.x","journal-title":"Transpl Infect Dis"},{"key":"ref31","doi-asserted-by":"crossref","DOI":"10.2307\/30141224","article-title":"Risk factors associated with isolation of Stenotrophomonas (Xanthomonas) maltophilia in clinical specimens","volume":"18","author":"VanCouwenberghe CJ","year":"1997","unstructured":"VanCouwenberghe CJ, Farver TB, Cohen SH. Risk factors associated with isolation of Stenotrophomonas (Xanthomonas) maltophilia in clinical specimens. Infect Control Hosp Epidemiol. 1997, 18:316-21.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-200205000-00006","article-title":"Clinical epidemiology of Stenotrophomonas maltophilia colonization and infection a multicenter study","volume":"81","author":"del Toro MD","year":"2002","unstructured":"del Toro MD, Rodr\u00edguez-Bano J, Herrero M, Rivero A, Garc\u00eda-Ordo\u00f1ez MA, Corzo J, P\u00e9rez-Cano R. Clinical epidemiology of Stenotrophomonas maltophilia colonization and infection a multicenter study. Medicine (Baltimore). 2002, 81:228-239. 10.1097\/00005792-200205000-00006","journal-title":"Medicine (Baltimore)"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1086\/599349","article-title":"Predicting mortality in patients with ventilator-associated pneumonia: The APACHE II score versus the new IBMP-10 score","volume":"49","author":"Mirsaeidi M","year":"2009","unstructured":"Mirsaeidi M, Peyrani P, Ramirez JA. Predicting mortality in patients with ventilator-associated pneumonia: The APACHE II score versus the new IBMP-10 score. Clin Infect Dis. 2009, 49:72-7. 10.1086\/599349","journal-title":"Clin Infect Dis"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2014.01.007","article-title":"Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: results from the SENTRY Antimicrobial Surveillance Program, 2009-2012","volume":"43","author":"Sader HS","year":"2014","unstructured":"Sader HS, Farrell DJ, Flamm RK, Jones RN. Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: results from the SENTRY Antimicrobial Surveillance Program, 2009-2012. Int J Antimicrob Agents. 2014, 43:328-34. 10.1016\/j.ijantimicag.2014.01.007","journal-title":"Int J Antimicrob Agents"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.00893","article-title":"Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options","volume":"6","author":"Chang YT","year":"2015","unstructured":"Chang YT, Lin CY, Chen YH, Hsueh PR. Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options. Front Microbiol. 2015, 6:893. 10.3389\/fmicb.2015.00893","journal-title":"Front Microbiol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph120505177","article-title":"Resistance of Stenotrophomonas maltophilia to Fluoroquinolones: Prevalence in a University Hospital and Possible Mechanisms","volume":"12","author":"Jia W","year":"2015","unstructured":"Jia W, Wang J, Xu H, Li G. Resistance of Stenotrophomonas maltophilia to Fluoroquinolones: Prevalence in a University Hospital and Possible Mechanisms. Int J Environ Res Public Health. 2015, 12:5177-95. 10.3390\/ijerph120505177","journal-title":"Int J Environ Res Public Health"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(09)70083-0","article-title":"Stenotrophomonas maltophilia: an emerging opportunist human pathogen. The","volume":"9","author":"Looney WJ","year":"2009","unstructured":"Looney WJ, Narita M, M\u00fchlemann K. Stenotrophomonas maltophilia: an emerging opportunist human pathogen. The. Lancet Infectious Dis. 2009, 9:312-323. 10.1016\/S1473-3099(09)70083-0","journal-title":"Lancet Infectious Dis"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1186\/1476-0711-5-23","article-title":"Stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: an increasing problem","volume":"5","author":"Al-Jasser AM","year":"2006","unstructured":"Al-Jasser AM. Stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: an increasing problem. Ann Clin Microbiol Antimicrob. 2006, 5:23. 10.1186\/1476-0711-5-23","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1086\/320183","article-title":"Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999)","volume":"32","author":"Gales AC","year":"2001","unstructured":"Gales AC, Jones RN, Forward KR, Li\u00f1ares J, Sader HS, Verhoef J. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999). Clin Infect Dis. 2001, 32:S104-13. 10.1086\/320183","journal-title":"Clin Infect Dis"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1080\/003655400459577","article-title":"Clinical implications of stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: a study of 69 patients at 2 university hospitals","volume":"32","author":"Tsiodras S","year":"2000","unstructured":"Tsiodras S, Pittet D, Carmeli Y, Eliopoulos G, Boucher H, Harbarth S. Clinical implications of stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: a study of 69 patients at 2 university hospitals. Scand J Infect Dis. 2000, 32:651-6. 10.1080\/003655400459577","journal-title":"Scand J Infect Dis"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1179\/joc.2008.20.1.38","article-title":"Antimicrobial susceptibility profile of contemporary clinical strains of Stenotrophomonas maltophilia isolates: can moxifloxacin activity be predicted by levofloxacin MIC results?","volume":"20","author":"Galles AC","year":"2008","unstructured":"Galles AC, Jones RN, Sader HS. Antimicrobial susceptibility profile of contemporary clinical strains of Stenotrophomonas maltophilia isolates: can moxifloxacin activity be predicted by levofloxacin MIC results?. J Chemother. 2008, 20:38-42. 10.1179\/joc.2008.20.1.38","journal-title":"J Chemother"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01264-21","article-title":"Minocycline activity against unusual clinically significant Gram-Negative pathogens","volume":"65","author":"Shortridge D","year":"2021","unstructured":"Shortridge D, Arends SJ, Streit JM, Castanheira M. Minocycline activity against unusual clinically significant Gram-Negative pathogens. Antimicrob Agents Chemother. 2021, 65:e0126421. 10.1128\/AAC.01264-21","journal-title":"Antimicrob Agents Chemother"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1179\/1120009X12Z.00000000022","article-title":"Tigecycline as a therapeutic option in Stenotrophomonas maltophilia infections","volume":"24","author":"Tek\u00e7e YT","year":"2012","unstructured":"Tek\u00e7e YT, Erbay A, Cabadak H, Sen S. Tigecycline as a therapeutic option in Stenotrophomonas maltophilia infections. J Chemother. 2012, 24:150-4. 10.1179\/1120009X12Z.00000000022","journal-title":"J Chemother"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00001-14","article-title":"Major variation in MICs of tigecycline in Gram-negative bacilli as a function of testing method","volume":"52","author":"Marchaim D","year":"2014","unstructured":"Marchaim D, Pogue JM, Tzuman O, et al.. Major variation in MICs of tigecycline in Gram-negative bacilli as a function of testing method. J Clin Microbiol. 2014, 52:1617-21. 10.1128\/JCM.00001-14","journal-title":"J Clin Microbiol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01603-19","article-title":"Activity of potential alternative treatment agents for Stenotrophomonas maltophilia isolates nonsusceptible to levofloxacin and\/or trimethoprim-sulfamethoxazole","volume":"58","author":"Biagi M","year":"2020","unstructured":"Biagi M, Tan X, Wu T, et al.. Activity of potential alternative treatment agents for Stenotrophomonas maltophilia isolates nonsusceptible to levofloxacin and\/or trimethoprim-sulfamethoxazole. J Clin Microbiol. 2020, 58:10.1128\/JCM.01603-19","journal-title":"J Clin Microbiol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired Pneumonia. an official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay JP","year":"2019","unstructured":"Metlay JP, Waterer GW, Long AC, et al.. Diagnosis and treatment of adults with community-acquired Pneumonia. an official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019, 200:e45-67. 10.1164\/rccm.201908-1581ST","journal-title":"Am J Respir Crit Care Med"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00019-11","article-title":"Stenotrophomonas maltophilia: an emerging global opportunistic pathogen","volume":"25","author":"Brooke JS","year":"2012","unstructured":"Brooke JS. Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev. 2012, 25:2-41. 10.1128\/CMR.00019-11","journal-title":"Clin Microbiol Rev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/77378-clinical-and-epidemiological-characteristics-of-stenotrophomonas-maltophilia-associated-lower-respiratory-tract-infections-in-qatar-a-retrospective-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:35:32Z","timestamp":1707507332000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/77378-clinical-and-epidemiological-characteristics-of-stenotrophomonas-maltophilia-associated-lower-respiratory-tract-infections-in-qatar-a-retrospective-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,17]]},"references-count":47,"URL":"https:\/\/doi.org\/10.7759\/cureus.23263","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,17]]}}}